| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0072 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.015 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |